3-v Biosciences, Inc.

Sagimet Biosciences Inc.

Lily W Hu

Haiying Cai

Cristiana A Zaharia

Russell J Johnson

Robert S McDowell

Johan D Oslob

Marc Evanchik

Hanbiao Yang

Allan S Wagman

Timothy Sean Heuer

Marie O'Farrell

Yamini Ohol-Gupta

Gregory Duke

Greg Duke

Robert S Mcdowell

Timothy Heuer

Marie O'FARRELL

Yamini Ohol

Marie O'farrell

Russell Johnson

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

Heterocyclic modulators of lipid synthesis and combinations thereof

Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders.

Heterocyclic modulators of lipid synthesis

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds.

Heterocyclic modulators of lipid synthesis for use against cancer and viral infections

Growing community of inventors

Palo Alto, CA, United States of America

Lily W Hu